Laboratorio Reig Jofre Future Growth
Future criteria checks 3/6
Laboratorio Reig Jofre is forecast to grow earnings and revenue by 16.1% and 8% per annum respectively. EPS is expected to grow by 17.2% per annum. Return on equity is forecast to be 4.3% in 3 years.
Key information
16.1%
Earnings growth rate
17.22%
EPS growth rate
| Pharmaceuticals earnings growth | 20.6% |
| Revenue growth rate | 8.0% |
| Future return on equity | 4.27% |
| Analyst coverage | Low |
| Last updated | 08 May 2026 |
Recent future growth updates
Recent updates
Reig Jofre Will Emerge Stronger Despite Temporary Setbacks
After reviewing Reig Jofre’s latest annual report and the Q1 2026 results, we are updating our 3-year fair value estimate to €3.29 per share , down from our previous €3.59 target published six months ago. The revision does not reflect a deterioration of the long-term business case, but rather a more realistic assessment of the pace of execution and margin recovery.Calculating The Fair Value Of Laboratorio Reig Jofre, S.A. (BME:RJF)
Key Insights Laboratorio Reig Jofre's estimated fair value is €3.07 based on 2 Stage Free Cash Flow to Equity With...These 4 Measures Indicate That Laboratorio Reig Jofre (BME:RJF) Is Using Debt Extensively
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...This Analyst Just Downgraded Their Laboratorio Reig Jofre, S.A. (BME:RJF) EPS Forecasts
The analyst covering Laboratorio Reig Jofre, S.A. ( BME:RJF ) delivered a dose of negativity to shareholders today, by...We Think Laboratorio Reig Jofre (BME:RJF) Is Taking Some Risk With Its Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Laboratorio Reig Jofre (BME:RJF) Seems To Use Debt Quite Sensibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...The Laboratorio Reig Jofre (BME:RJF) Share Price Has Gained 146%, So Why Not Pay It Some Attention?
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company...Is Laboratorio Reig Jofre (BME:RJF) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Laboratorio Reig Jofre (BME:RJF) Shareholders Booked A 47% Gain In The Last Year
It might be of some concern to shareholders to see the Laboratorio Reig Jofre, S.A. ( BME:RJF ) share price down 15% in...Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2028 | 420 | 13 | 7 | N/A | 1 |
| 12/31/2027 | 392 | 10 | 6 | N/A | 1 |
| 12/31/2026 | 365 | 17 | -5 | N/A | 1 |
| 3/31/2026 | 335 | 4 | N/A | N/A | N/A |
| 12/31/2025 | 337 | 5 | -17 | 2 | N/A |
| 9/30/2025 | 330 | 4 | N/A | N/A | N/A |
| 6/30/2025 | 337 | 6 | 7 | 31 | N/A |
| 3/31/2025 | 343 | 11 | N/A | N/A | N/A |
| 12/31/2024 | 341 | 10 | 11 | 31 | N/A |
| 9/30/2024 | 334 | 10 | N/A | N/A | N/A |
| 6/30/2024 | 334 | 9 | -3 | 16 | N/A |
| 3/31/2024 | 326 | 9 | N/A | N/A | N/A |
| 12/31/2023 | 318 | 9 | 6 | 19 | N/A |
| 9/30/2023 | 316 | 12 | N/A | N/A | N/A |
| 6/30/2023 | 298 | 10 | 6 | 18 | N/A |
| 3/31/2023 | 286 | 10 | N/A | N/A | N/A |
| 12/31/2022 | 274 | 8 | 5 | 16 | N/A |
| 9/30/2022 | 262 | 4 | N/A | N/A | N/A |
| 6/30/2022 | 256 | 5 | -6 | 5 | N/A |
| 3/31/2022 | 245 | 3 | N/A | N/A | N/A |
| 12/31/2021 | 240 | 5 | -5 | 14 | N/A |
| 9/30/2021 | 237 | 6 | N/A | N/A | N/A |
| 6/30/2021 | 234 | 5 | 9 | 22 | N/A |
| 3/31/2021 | 234 | 6 | N/A | N/A | N/A |
| 12/31/2020 | 234 | 6 | 7 | 19 | N/A |
| 9/30/2020 | 229 | 8 | N/A | N/A | N/A |
| 6/30/2020 | 229 | 6 | -15 | 14 | N/A |
| 3/31/2020 | 219 | 6 | N/A | N/A | N/A |
| 12/31/2019 | 206 | 5 | N/A | 12 | N/A |
| 9/30/2019 | 199 | 7 | N/A | N/A | N/A |
| 6/30/2019 | 188 | 9 | N/A | 16 | N/A |
| 3/31/2019 | 188 | 9 | N/A | N/A | N/A |
| 12/31/2018 | 185 | 9 | N/A | 15 | N/A |
| 9/30/2018 | 185 | 10 | N/A | N/A | N/A |
| 6/30/2018 | 179 | 9 | N/A | 14 | N/A |
| 3/31/2018 | 175 | 9 | N/A | N/A | N/A |
| 12/31/2017 | 172 | 9 | N/A | 21 | N/A |
| 9/30/2017 | 164 | 5 | N/A | N/A | N/A |
| 6/30/2017 | 164 | 7 | N/A | 8 | N/A |
| 3/31/2017 | 164 | 8 | N/A | N/A | N/A |
| 12/31/2016 | 161 | 8 | N/A | -1 | N/A |
| 9/30/2016 | 160 | 5 | N/A | N/A | N/A |
| 6/30/2016 | 159 | 5 | N/A | 8 | N/A |
| 3/31/2016 | 156 | 5 | N/A | N/A | N/A |
| 12/31/2015 | 157 | 9 | N/A | 13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RJF's forecast earnings growth (16.1% per year) is above the savings rate (2.7%).
Earnings vs Market: RJF's earnings (16.1% per year) are forecast to grow faster than the Spanish market (11.4% per year).
High Growth Earnings: RJF's earnings are forecast to grow, but not significantly.
Revenue vs Market: RJF's revenue (8% per year) is forecast to grow faster than the Spanish market (6.6% per year).
High Growth Revenue: RJF's revenue (8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: RJF's Return on Equity is forecast to be low in 3 years time (4.3%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/25 20:01 |
| End of Day Share Price | 2026/06/25 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Laboratorio Reig Jofre, S.A. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Francisco Ruiz | BNP Paribas |
| Alfredo Echevarria Otegui | Lighthouse-IEAF Servicios de Analisis |
| Luis Esteban Arribas | Lighthouse-IEAF Servicios de Analisis |